Your browser doesn't support javascript.
loading
NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin.
Yeo, Winnie; Lau, Thomas Kh; Kwok, Carol Ch; Lai, Kwai T; Chan, Vicky Tc; Li, Leung; Chan, Vivian; Wong, Ashley; Soo, Winnie Mt; Yeung, Eva Wm; Wong, Kam H; Tang, Nelson Ls; Suen, Joyce Js; Mo, Frankie Kf.
Afiliación
  • Yeo W; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, Hong Kong winnieyeo@cuhk.edu.hk.
  • Lau TK; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Kwok CC; Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, Hong Kong.
  • Lai KT; Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, New Territories, Hong Kong.
  • Chan VT; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Li L; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Chan V; Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, New Territories, Hong Kong.
  • Wong A; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Soo WM; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Yeung EW; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Wong KH; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Tang NL; Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, New Territories, Hong Kong.
  • Suen JJ; Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong.
  • Mo FK; Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, New Territories, Hong Kong.
BMJ Support Palliat Care ; 12(e2): e264-e270, 2022 Jul.
Article en En | MEDLINE | ID: mdl-31996363
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: BMJ Support Palliat Care Año: 2022 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: BMJ Support Palliat Care Año: 2022 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: Reino Unido